Company Filing History:
Years Active: 2022
Title: Heba Al Khatabi: Innovator in Stroke Treatment
Introduction
Heba Al Khatabi is a prominent inventor based in Jeddah, Saudi Arabia. She has made significant contributions to the field of medical innovation, particularly in the treatment of stroke patients with comorbidities. Her work focuses on enhancing existing therapies to improve patient outcomes.
Latest Patents
Heba holds a patent for a groundbreaking invention titled "GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke." This patent addresses the challenges faced by stroke patients who also suffer from conditions such as diabetes and hypertension. The invention proposes the use of an inhibitor of S-nitrosoglutathione reductase (GSNOR) in conjunction with remote ischemic conditioning (RIC) to enhance the effectiveness of thrombolytic therapies. This innovative approach allows for effective treatment even after five hours post-onset of stroke, providing new hope for patients with comorbidities.
Career Highlights
Heba is affiliated with King Abdulaziz University, where she continues to advance her research and innovation in the medical field. Her dedication to improving stroke treatment has positioned her as a key figure in medical research and innovation.
Collaborations
Heba collaborates with esteemed colleagues, including Syed Kashif Zaidi and Md Nasrul Hoda. Their combined expertise contributes to the development of effective therapies for stroke patients.
Conclusion
Heba Al Khatabi's innovative work in stroke treatment exemplifies the impact of research and invention in addressing complex medical challenges. Her contributions are paving the way for improved therapies that can significantly enhance patient care.